The REDACT Act amends the Epstein Files Transparency Act to allow private individuals to sue the federal government if their personal or medical information is improperly disclosed in released documents. Under this new provision, victims can file a civil lawsuit against the United States if an official fails to redact data that would constitute an unwarranted invasion of privacy. If a person wins the case, they could receive up to $50,000 for each violation, plus compensation for emotional distress and legal fees. The law applies to violations occurring on or after November 19, 2025, and gives plaintiffs five years from the date they learn of the breach to file a claim.
The Medicare Advantage MLR Transparency Act requires insurance companies offering Medicare Advantage plans to publicly disclose detailed financial data starting in 2029. Under this bill, each plan must report how much total revenue it collects and specifically how much is spent on actual medical claims versus administrative overhead costs. The law also mandates that this financial information be presented in a consumer-friendly format and aligns the way benefits are displayed with standards used by other health insurance plans. These changes aim to give Medicare beneficiaries clearer insight into how their premiums are utilized by the plans they choose.
The Medical Bankruptcy Fairness Act of 2026 creates a special legal category for individuals overwhelmed by medical bills, allowing them to receive more favorable treatment in bankruptcy court. To qualify as a "medically distressed debtor," a person must have incurred significant unpaid medical costs or lost income due to illness, injury, or caregiving within the last three years. The bill grants these individuals an additional $250,000 exemption for their primary home or burial plot, waives certain financial tests required to file for Chapter 7 bankruptcy, and prevents their bankruptcy records from appearing on credit reports. Furthermore, the law makes it easier for medically distressed debtors to discharge student loans and simplifies the paperwork they must submit to the court. These changes aim to provide relief specifically for those whose financial hardship stems directly from medical issues.
The K-9 Hero Act of 2026 establishes a grant program to help cover medical costs for retired federal working dogs, directly affecting nonprofit organizations that provide care or financial aid to their owners. Starting in fiscal year 2027, the Secretaries of Defense and Homeland Security will jointly award grants to eligible nonprofits, with a maximum of $1 million per organization per year, to pay for veterinary treatment, surgeries, and necessary health supplies. To ensure accountability, recipients must submit annual reports on how the funds are used, and any unspent money will reduce the grant amount for the following year. The legislation authorizes $5 million annually for four years and requires the agencies to track health outcomes and report their findings to Congress every year until 2031.
This bill requires hospitals that receive federal health care funding to ask patients about their immigration status during admission and report the results to government agencies. Under the law, hospitals must include a specific statement on intake forms assuring patients that their answers will not affect their medical care or lead to a law enforcement report unless the patient is suspected of certain crimes. Hospitals must also submit quarterly reports detailing how many patients are citizens, lawful residents, or undocumented, along with the number of individuals who refused to answer or failed to provide proof of their legal status. The legislation prohibits hospitals from sharing personal identifying information with the government while allowing them to exclude non-compliant facilities from federal programs. Additionally, the bill mandates an annual report to Congress analyzing the costs of uncompensated care for undocumented patients and its impact on hospital services.
This bill requires hospitals, laboratories, imaging centers, and ambulatory surgical centers to publicly post detailed price lists for their services, including standard charges, negotiated rates, and discounted cash prices, starting in 2027. It also mandates that private health insurance plans provide consumers with cost-sharing estimates and publish quarterly data on payment rates to doctors and pharmacies beginning in 2029. Additionally, the legislation requires Medicare Advantage and prescription drug plan sponsors to report ownership details for providers and pharmacies they control, while establishing civil penalties for entities that fail to comply with these transparency rules.
The Medicare Access to Rural Anesthesiology Act changes how Medicare pays for anesthesia services at specific small rural hospitals and critical access hospitals. To qualify for these changes, a hospital must be located in a rural area, have fewer than 800 surgeries requiring anesthesia, and employ or contract with no more than one full-time anesthesiologist who agrees not to bill Medicare separately for those services. Once a hospital meets these criteria, anesthesia care provided by an anesthesiologist there will be paid based on the hospital's actual costs rather than a fixed fee, and it will be classified as part of the hospital's inpatient services instead of a separate billable service. The law also requires the Department of Health and Human Services to update its regulations to reflect these new payment rules.
This bill, known as the Getting Innovations to Patients During Shutdowns Act, allows the Food and Drug Administration to continue reviewing applications for new drugs and medical devices even if the government funding for these programs lapses. Under the new rules, the FDA may accept incomplete applications that are missing only fee payments and will automatically extend the deadline to pay those fees by seven days after the funding gap ends. If the required fees are not paid by this extended deadline, the application will be treated as rejected and cannot be approved until the payment is made. The legislation aims to prevent government shutdowns from halting the evaluation of critical medical products while ensuring that necessary fees are still collected.
This bill, titled the Ban Abortion by Mail Act, aims to restrict how abortion medications like mifepristone are prescribed by requiring an in-person visit between the patient and the doctor. It directly affects health care providers who are currently certified by the FDA to dispense these drugs, threatening their certification status if they prescribe them without a physical examination or to patients living in states where the provider lacks a medical license. The legislation mandates that the FDA report annually to Congress on any providers who lose this certification due to violations or unsafe prescribing practices. By enforcing these specific conditions, the bill seeks to ensure that all prescriptions for abortion drugs are administered under strict supervision and within the legal boundaries of the patient's state.
This bill directs the Department of Defense to review clinical trial data on psilocybin treatment for veterans and servicemembers with treatment-resistant PTSD. It requires the Assistant Secretary of Defense for Health Affairs to submit a report within 180 days analyzing the safety, dosing, and feasibility of these findings for military personnel, including those transitioning to civilian life. The report must also assess legal requirements for expanded access to the substance and outline plans for future pilot programs or research starting in fiscal year 2027. Additionally, the legislation mandates coordination with the Department of Veterans Affairs and other federal agencies to ensure continuity of care and appropriate regulatory oversight.